Skip to main content
. 2022 May 18;187(2):323–333. doi: 10.1530/EJE-22-0108

Table 2.

Urinary steroid profiling characteristics table following intervention. Data are presented as mean ± s.d.. There was no statistical significance between CWM and surgery at baseline.

Baseline 12 Months
CWM (16) Surgery (13) CWM (16) Surgery (13)
Age (years) 31.8 ± 7.9 32.6 ± 7.4
BMI (kg/m2) 44.7 ± 8.1 44.0 ± 7.6 44.1 ± 8.8 34.0 ± 8.0**,####
ICP (cmCSF) 32.6 ± 4.8 35.2 ± 5.1 30.3 ± 5.6 23.6 ± 6.6**,####
Sex (female, %) 100% 100%
Fasting insulin (mIU/L) 17.4 ± 7.6 10.7 ± 3.8 14.7 ± 6.1$$ 4.3 ± 4.3*,###
HOMA2-IR 1.9 ± 0.8 1.5 ± 0.6 1.1 ± 0.4 $$ 0.4 ± 0.4*, ###
Leptin (ng/mL) 89.3 ± 37.0 76.8 ± 32.2 79.3 ± 38.8 31.9 ± 24.0***, ####
IL-6 (pg/mL) 5.8 ± 2.7 6.3 ± 2.1 5.4 ± 1.9 5.0 ± 2.1
Urine (µg/24 h)
 5α-THF 518 ± 537 324 ± 304 897 ± 641$ 403 ± 304*
 THF 2305 ± 1708 2058 ± 1406 2640 ± 1309 1967 ± 899
 THE 3435 ± 2121 2666 ± 1741 5055 ± 2231$ 3780 ± 1836
 Cortisol (F) 69 ± 51 63 ± 47 65 ± 27 66 ± 25
 Cortisone (E) 90 ± 70 73 ± 41 118 ± 52 106 ± 55
 Total GC metabolites 10057 ± 5881 7502 ± 4806 14138 ± 6597 12195 ± 6026
Derivative measurements
 5α-THF+THF/THE 0.799 ± 0.14 0.933 ± 0.22 0.699 ± 0.13 0.660 ± 0.16####
 F/E 0.812 ± 0.56 0.816 ± 0.24 0.563 ± 0.11$$$$ 0.683 ± 0.22#
 5α-THF/THF 0.231 ± 0.10 0.188 ± 0.14 0.32 ± 0.13$$ 0.22 ± 0.09

*Statistical comparisons between CWM and surgery at 12 months; #Statistical comparison between surgery baseline and surgery 12 months; $Statistical comparison between CWM baseline and surgery 12 months; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

cmCSF, centimeters of cerebrospinal fluid; GC, glucocorticoid; HOMA, homeostatic model assessment; ICP, intracranial pressure; IL-6, interleukin 6; THE, tetrahydrocortisone; THF, tetrahydrocortisol; 5α-THF, 5α-tetrahydrocortisol.